Table 3.
Histopathological parameter | GCA symptom duration | ESR | CRP | Platelets | Hemoglobin | Fibrinogen |
---|---|---|---|---|---|---|
[days] | [mm/h] | [mg/ml] | [109/l] | [mg/ml] | [mg/ml] | |
CD3+ [cells/mm2] | 0.144 | –0.050 | 0.195 | 0.048 | 0.164 | –0.011 |
CD4+ [cells/mm2] | 0.186 | –0.036 | 0.204 | 0.044 | 0.176 | –0.007 |
CD8+ [cells/mm2] | 0.068 | 0.040 | 0.239 | 0.113 | 0.088 | 0.130 |
CD4+:CD8+ ratio | –0.046 | 0.076 | –0.263 | –0.003 | 0.025 | –0.132 |
NFATC+ [cells/mm2] | 0.161 | 0.027 | 0.213 | 0.085 | 0.184 | 0.041 |
NFATC+:CD4+ ratio | –0.079 | 0.190 | 0.209 | 0.188 | 0.106 | 0.280 |
CD20+ [cells/mm2] | 0.100 | –0.143 | 0.084 | 0.032 | 0.191 | 0.078 |
CD68+ [score] | 0.091 | 0.024 | 0.248 | 0.128 | 0.038 | 0.220 |
MGCs [score] | 0.074 | 0.062 | 0.313* | 0.134 | 0.090 | 0.113 |
Eosinophils [score] | –0.110 | 0.108 | 0.344* | 0.130 | 0.177 | 0.091 |
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; MGC, multinucleated giant cell. Spearman’s correlation coefficients (ρ) between evaluated parameters of 46 GCA patients, including 30 TAB-positive and 16 TAB-negative GCA patients. A p-value of < 0.05 was considered statistically significant (*p < 0.05) (marked in bold).